Updated bngo stock forecast notes that recent grant awards for genomic research could indirectly boost demand for its optical genome mapping systems, impacting revenues positively by late Support, Risk & Stop-Loss For Bionano Genomics Stock There are two main reasons for my optimism. First, in the last month, the stock market in general and growth stocks, in particular, have performed very well. Secondly bullish statements made earlier this month by the very successful, veteran investor Ed Yardeni make me think hot growth stocks are about to get a lot more attractive. Analysts warn in their bngo stock forecast assessments that any delay in product upgrades could limit upside movement. Market reaction tends to be swift in the biotech space when innovation cycles slow.